Tag: collaboration

BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR). GIPR, an incretin receptor, is a validated target for peptide-based parenteral therapies where both stimulation and inhibition has shown efficacy in treating obesity and its co-morbidities. RenaissThera is developing novel, oral small molecules, both agonists and antagonists, as a more affordable and convenient alternative aiming to expand access for underserved populations in the global obesity market projected to reach USD 38 billion by 2032. Oral small molecules are more economical to manufacture and distribute than peptide-based obesity drugs. These molecules were designed and screened using proprietary AI and ML based platforms, followed by demonstrating in-vitro activity in cell lines and in-vivo activity to impact GIPR in mice to yield “Hits”. RenaissThera now is advancing these Hits to the Lead optimization program to select candidates for pre-IND studies.

Johor Bahru, June 09, 2025 (GLOBE NEWSWIRE) -- JYSigma Business Consultancy (JBC), a fast-growing strategic advisory firm based in Singapore and Malaysia, has signed a landmark partnership agreement with Asia Vision Capital Sdn. Bhd (AVC), a licensed venture capital management corporation registered and regulated by the Securities Commission of Malaysia. The collaboration officially launches JBC’s participation in a Shariah-compliant private equity fund anchored by the Quayside JBCC mixed-use development in Johor Bahru.